Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.pmrj.2016.07.448 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Design and rationale of the Engage-HF study: the impact of a gamified engagement toolkit on participation and engagement in a heart failure registry.
Eur Heart J Digit Health
September 2024
Department of Cardiology, Amphia Hospital, Molengracht 21, 4818 CK Breda, The Netherlands.
Article Synopsis
- This study evaluates the impact of an educational engagement toolkit on increasing participation rates and data completeness among heart failure (HF) nurse practitioners in the NHR-HF registry.
- The Engage-HF study involves a 24-week program using a gamified smartphone app called BrightBirds, along with interactive materials to enhance learning and engagement.
- The research aims to address the challenges faced by healthcare professionals in participating in registries by providing efficient and innovative methods for education on the latest heart failure guidelines.
Is doxycycline post-exposure prophylaxis being utilised in Germany? Insights from an online survey among German men who have sex with men.
Infection
July 2024
TUM School of Medicine and Health, Department of Clinical Medicine, Clinical Department for Internal Medicine II, University Medical Center, Technical University of Munich, Munich, Germany.
Article Synopsis
- Doxycycline post-exposure prophylaxis (Doxy-PEP) significantly lowers the risk of Chlamydia and early syphilis by about two-thirds, but data on its use among men who have sex with men (MSM) is sparse.
- A national online survey in Germany engaged 438 MSM and transgender women, revealing that 38.8% were aware of Doxy-PEP, and 62.8% would consider using it; however, only 7.3% had actually used it.
- Participants expressed concerns about the lack of detailed information and antibiotic resistance as barriers to usage, highlighting a gap between awareness and actual uptake of Doxy-PEP among MSM, particularly those living with
Zebrafish from the Alps to Sicily: The 4th Italian Zebrafish Meeting in Palermo.
Zebrafish
August 2024
Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STeBiCeF), University of Palermo, Palermo, Italy.
Article Synopsis
- The 4th Italian Zebrafish Meeting took place in Palermo from February 7 to 9, 2024, gathering researchers, facility managers, and vendors to discuss innovative zebrafish research in Italy and beyond.
- The event featured 210 participants who presented their work through talks and posters, promoting an open exchange of ideas and fostering networking opportunities for attendees at all career stages.
- This year's meeting was the most successful to date, showcasing a wide range of scientific topics and receiving high satisfaction ratings from participants.
Commercially Available Home Pelvic Training Devices for the Treatment of Pelvic Floor Disorders: A Systematic Review and Meta-analysis.
Obstet Gynecol
August 2022
Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; the Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Medstar Health Research Institute, Hyattsville, Maryland; and the Section of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Medstar Washington Hospital Center/Georgetown University School of Medicine, Washington, DC.
Objective: To assess the clinical efficacy of commercially available pelvic muscle training devices on the treatment of pelvic floor disorders.
Data Sources: We searched MEDLINE, Web of Science, and ClinicalTrials.gov through April 2020.
Data privacy protection in scientific publications: process implementation at a pharmaceutical company.
BMC Med Ethics
June 2022
Baxalta Innovations GmbH, A Takeda Company, Vienna, Austria.
Background: Sharing anonymized/de-identified clinical trial data and publishing research outcomes in scientific journals, or presenting them at conferences, is key to data-driven scientific exchange. However, when data from scientific publications are linked to other publicly available personal information, the risk of reidentification of trial participants increases, raising privacy concerns. Therefore, we defined a set of criteria allowing us to determine and minimize the risk of data reidentification.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!